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Background
Breast cancer is the most frequent and most deadly can-
cer in females and incidence rates are increasing at an
alarming rate in Saudi Arabia [1]. Studies have shown
the potential of gene expression profiling in discovering
biomarkers and molecular genetic signatures for breast
cancer [2-4]. However, such discoveries and association
of expression profiling with different type of Saudi Ara-
bian breast cancer patients are largely unexplored.
Materials and methods
We performed transcriptomic profiling of 42 surgically-
resected breast tumors (n=23 lymph node positive; n=19
lymph node negative) using Affymetrix Gene 1.0 ST chip.
Partek Genome Suit 6.4 and Ingenuity Pathway Analysis
package were used for identification of differentially
expressed genes, hierarchical clustering, gene ontology,
pathway analysis and establishing clinical significance.
Results
We identified 30 differentially expressed genes, including
10 up and 20 down-regulated in lymph node involved
breast cancer using cut off of p value <0.05 and fold
change >2. Ceruloplasmin (CP), immunoglobulin J poly-
peptide (IJP), cellular retinoic acid binding protein 1
(CRABP1), keratin 23 (KRT23), paraoxonase 3 (PON3),
and integrin beta 6 (ITGB6) genes were up-regulated
whereas genes like AF4/FMR2 family member 3 (AFF3),
v-erb-a erythroblastic leukemia viral oncogene homolog
4 (ERBB4), anterior gradient homolog 2 (AGR2), serpin
peptidase inhibitor clade A (SERPINA5), and POTE
ankyrin domain family member E (POTEE) were downre-
gulated. Transcriptomic signatures showed significant dis-
ruption in signaling pathways associating genes of the B-
Cell development, Hematopoiesis from Pluripotent Stem
Cells, Primary Immunodeficiency Signaling, Fatty Acid
Biosynthesis Initiation II and LXR/RXR Activation.
Conclusions
In the present study, we identified transcriptomic signa-
ture in Saudi breast cancer patients that is associated
with lymph node metastasis. Our analysis reveals appro-
priate biological relevance and a number of molecular
pathways that may serve as targets for novel therapeutics.
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